Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL586P is a pseudogene of the 7SL RNA family. The 7SL RNA is a non-coding RNA that is a component of the signal recognition particle (SRP), which directs nascent proteins to the endoplasmic reticulum. However, RN7SL586P itself is classified as a pseudogene, meaning it resembles the functional gene but is generally considered non-coding and non-functional—the result of gene duplication or retrotransposition events. Pseudogenes like RN7SL586P do not code for proteins and typically do not have direct biological functions, though some pseudogenes can have regulatory roles in gene expression or act as competitive endogenous RNAs (ceRNAs). RN7SL586P has no documented role as a therapeutic target, no known drug interactions, and is not associated with specific diseases or clinical biomarkers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 586, pseudogene (RN7SL586P).